GLUE — Monte Rosa Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1826457 ·
Last close
$13.77
Market Cap
$1.18B
52W High
$25.22
52W Low
$13.33
ADV30
1,362,646
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 8,968,000 | — | -49,130,000 | -43,397,000 | 691,161,000 | 90,104,000 | 203,880,000 |
| Mar 2026 | 4,210,000 | — | -50,034,000 | -44,503,000 | 736,428,000 | 159,859,000 | 214,512,000 |
| Dec 2025 | 2,781,000 | — | -49,715,000 | -46,135,000 | 448,659,000 | 129,883,000 | 215,603,000 |
| Sep 2025 | 12,768,000 | — | -32,975,000 | -27,081,000 | 459,841,000 | 208,343,000 | 214,004,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-24,069,000
Investing CF
$-316,785,000
Financing CF
$361,518,000
CapEx
$-8,009,000
Dividends Paid
—
Buybacks
$-357,000
EPS Diluted TTM
$-2.18
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-565,114,000
Inventory
—
Receivables
$4,920,000
ST Investments
$531,000,000
EBIT TTM
$-181,854,000
Pretax Income TTM
$-163,974,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$28,727,000
EBITDA
$-173,728,000
Free Cash Flow
$-74,449,752
Enterprise Value
$636,864,640
Total Cash
$621,104,000
Total Debt
$37,987,000
Shares Out
85,313,401
Trailing EPS
$-1.75
Book Value
$5.72
ROE
-42.7%
ROA
-21.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 123,672,000 | -54,208,000 | -38,626,000 | 448,659,000 | 215,603,000 | — | -22,798,000 |
| Dec 2024 | 75,622,000 | -81,112,000 | -72,700,000 | 438,732,000 | 215,796,000 | — | 41,996,000 |
| Dec 2023 | 0 | -143,311,000 | -135,352,000 | 303,755,000 | 124,505,000 | — | -43,802,000 |
| Dec 2022 | 0 | -112,384,000 | -108,501,000 | 342,389,000 | 70,976,000 | — | -92,466,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.88
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $12.50 · spot: $13.77 · call volume: 1,188 · put volume: 35
Expected Move to 2026-09-18:
±$4.25
(30.85%) —
implied range
$9.52 –
$18.02
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IMTX | Immatics N.V. | $1.19B | $8.69 | — |
| ODTX | Odyssey Therapeutics, Inc. | $1.21B | $25.15 | — |
| SANA | Sana Biotechnology, Inc. | $1.13B | $3.78 | — |
| VOR | Vor Biopharma Inc. | $1.23B | $22.71 | — |
| REPL | Replimune Group, Inc. | $1.39B | $14.71 | — |
News headlines (Yahoo Finance, 1h cache)
Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant P
2026-08-24 11:00 · Yahoo
Monte Rosa Therapeutics (GLUE) Is Down 30.7% After Deepening Q2 Losses And H1 Earnings Reversal
2026-08-07 07:10 · Yahoo
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-02 20:01 · Yahoo
After a 400% Surge, Should Investors Care About This $882,000 Monte Rosa Insider Sale?
2026-06-29 22:50 · Yahoo
Monte Rosa Therapeutics (GLUE): Best Growth Stocks Under $20 to Buy
2026-06-03 18:00 · Yahoo
Monte Rosa Trial Progress And Valuation Gap Draw Investor Attention
2026-05-10 00:24 · Yahoo
Monte Rosa Therapeutics (GLUE) Reports Q1 Loss, Misses Revenue Estimates
2026-05-07 15:15 · Yahoo
Monte Rosa Therapeutics Announces First Quarter 2026 Financial Results and Business Updates
2026-05-07 11:00 · Yahoo
Monte Rosa CEO Sells $141K in Stock Amid 300% Surge and Recent Capital Raise
2026-04-21 17:53 · Yahoo
Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to T
2026-04-20 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.